Please use this identifier to cite or link to this item:
http://dspace.bsmu.edu.ua:8080/xmlui/handle/123456789/12115
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Pavlyukovich, N. | |
dc.contributor.author | Pavlyukovich, O. | |
dc.contributor.author | Buriak, O.G. | |
dc.contributor.author | Chympoy, C. | |
dc.date.accessioned | 2017-02-20T10:47:40Z | |
dc.date.available | 2017-02-20T10:47:40Z | |
dc.date.issued | 2016 | |
dc.identifier.other | УДК 616.12-008.46:616.379-008.64]-07-0361-085.225.2 | |
dc.identifier.uri | http://dspace.bsmu.edu.ua:8080/xmlui/handle/123456789/12115 | |
dc.description.abstract | Chronic heart failure of ischemic origin complicated by concomitant diabetes mellitus type 2 is characterized by significant decreasing of the quality of life in general, and of physical and psychological welfare, self-service and independence of action, same as personal implementation particularly. Inclusion of telmisartan to the scheme of complex treatment of the patients with chronic heart failure and diabetes mellitus type 2 results in the improvement of the patients’ quality of life as well as its main components | ru_RU |
dc.language.iso | en | ru_RU |
dc.publisher | “THE UNITY OF SCIENCE” April, 2016 | ru_RU |
dc.subject | chronic heart failure | ru_RU |
dc.subject | diabetes mellitus type 2 | ru_RU |
dc.subject | quality of life | ru_RU |
dc.subject | telmisartan | ru_RU |
dc.title | CHRONIC HEART FAILURE AND DIABETES MELLITUS TYPE 2: QUALITY OF LIFE AND POSSIBILITY OF ITS CORRECTION | ru_RU |
dc.type | Article | ru_RU |
Appears in Collections: | Статті |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
Chronic heart failure and diabetes mellitus type 2 quality of life and possibility of its correction.pdf | 13.49 MB | Adobe PDF | View/Open |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.